April 29, 2022 08:19 ET | Source: ReportLinker ReportLinker

New York, April 29, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Diabetes Diagnostics Industry" - https://www.reportlinker.com/p04368322/?utm_source=GNW -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass Research Platform -Complimentary updates for one year Global Diabetes Diagnostics Market to Reach $42.4 Billion by 2026 Diabetes diagnostics systems are used to measure blood glucose levels or blood sugar levels, which indicates whether or not a person is suffering from diabetes. Demand for diabetes diagnostics devices and systems is being driven by the need for easier, economic, and efficient management of the global diabetes epidemic, improving ease-of-use and accuracy of devices, and development of non-invasive techniques to simplify regular glucose testing. The spread of diabetes at epidemic proportions is driving the requirement for pre-diabetics testing and post-prandial glucose-level monitoring. With increasing levels of patient education on possible ways of preventing and delaying the onset of Type II diabetes, more and more pre-diabetics are expected to start testing blood glucose. Added to this, patients undergoing tests on account of complications arising from undiagnosed condition, such as heart attacks, are likely to spur market potential. Increasing obesity levels globally coupled with growing requirements of aging patients at both facility-based geriatric care as well as home-based managed care facilities is also expected to drive demand for various diabetes diagnostic devices and systems. Technology advancements in diabetes diagnostics that are poised to benefit market prospects in the near term include mHealth Solutions for diabetes diagnosis; wearable glucose testing devices; implantable continuous glucose monitor; and cloud-enabled CGM devices, among others. Amid the COVID-19 crisis, the global market for Diabetes Diagnostics estimated at US$26.5 Billion in the year 2020, is projected to reach a revised size of US$42.4 Billion by 2026, growing at a CAGR of 8.1% over the analysis period. Test Strips, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$11.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lancets segment is readjusted to a revised 7.5% CAGR for the next 7-year period. Blood glucose test strips are small disposable strips of plastic that enable people with diabetes to measure and monitor their blood sugar levels at home. Each test strip is a laminate of plastic and chemicals that provides a single-use diagnostic test for measuring blood sugar. Persistent growth in the blood glucose test strips market has been driven to a greater extent by an increase in number of diabetics, and also by technological innovations. Blood sugar lancets play a vital role in the early detection of diabetes. The rising prevalence of diabetes, favorable reimbursement policies in developed countries, rising geriatric population, continuous technological advancements, and faster product approvals are some of the key factors spurring demand. The U.S. Market is Estimated at $10.8 Billion, While China is Forecast to Reach $5.2 Billion by 2026 The Diabetes Diagnostics market in the U.S. is estimated at US$10.8 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2026 trailing a CAGR of 9.7% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR. Growing prevalence of diabetes and other lifestyle and chronic diseases, ageing population, well-established healthcare infrastructure and wider access to care services, higher healthcare awareness among population, and consumer affluence strongly influence the demand for care and diagnostics services in developed countries. Asia-Pacific represents a rapidly expanding market for diabetes diagnostics. Increased convenience, shift towards high-calorie energy-rich foods, and increasingly sedentary lifestyles are contributing to an alarming rise in incidence of diabetes in India and China making the countries the global hub for the disease with the highest number of diabetic adults. Analog Glucose Monitors Segment to Reach $5.2 Billion by 2026 Analog glucose monitors are traditional blood glucose meters that uses a blood sample drawn from pricking a patient`s finger or another place on the body. In the global Analog Glucose Monitors segment, USA, Canada, Japan, China and Europe will drive the 6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.9 Billion in the year 2020 will reach a projected size of US$4.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$579.9 Million by the year 2026, while Latin America will expand at a 7.5% CAGR through the analysis period. Select Competitors (Total 91 Featured) -

Read the full report: https://www.reportlinker.com/p04368322/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of COVID-19 and a Looming Global Recession Technologies Come to the Aid for Diabetes Diagnosis, Monitoring and Management Diabetes: A Chronic Body Disorder An Introduction to Diabetes Diagnostics Diabetes Diagnostics: Easier, Economic, and Efficient Management of the Global Diabetes Epidemic Developed Regions Lead, Developing Economies to Spearhead Future Growth Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices World Diabetes and Population Statistics (2019, 2030 & 2045) Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045 World Diabetes Prevalence (2000-2019) Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2019 and 2045 Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045 Diabetes Emerges as One of the Leading Causes of Mortality Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019 Competition Global Continuous Glucose Monitoring Market Breakdown (in %) by Leading Competitors for 2019 Global Blood Glucose Monitoring Devices Market Share (in %) by Company for 2019 Quality Products at Low Prices: Mantra for Success in the Marketplace SMBG Makers Turn to Mobile Devices to Woo Users on the Move World Brands Recent Market Activity Diabetes Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030 Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023 Diabetes-Related Health Expenditure: Average Spending Per Person (in US$) by Region for 2010 and 2019 Increasing Obesity Levels Underpins Market Growth Average Per Capita Annual Health Expenditure (In US$) due to Obesity Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P Rising Importance of Real-Time Glucose Sensing and Monitoring Drive Robust Growth in Minimally-Invasive CGM Devices Market Global Continuous Glucose Monitoring Systems Market by Component for 2020E Global Continuous Glucose Monitoring Systems Market by End-Use (in %) for 2020E CGM Demand Benefits from the COVID-19 Pandemic CGM Market Breaks through Barriers to Witness Growing Adoption Growing Role of HbA1c Testing Devices in Monitoring & Management of Diabetes Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption Glycated Albumin: A Potential Threat to HbA1c Role of HbA1c Testing in Diabetes Diagnosis and Management HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Witness Demand Growth Blood Glucose Strips: Low Cost Advantage Augurs Drives Market Blood Sugar Lancets Market: Sustained Growth in Demand Self-Monitoring/Household Blood Glucose Sustains Market Growth Rising Smartphone Penetration Augurs Well for SMBG Market Smartphone Penetration Rate as Share of Total Population: 2016 -2020 Barriers to Adoption of New Technology in BGM Products Accuracy Issues Plague Blood Glucose Meters Market Insulin Pens Rise in Popularity for Administering Insulin Smart Insulin Pens Increasing Role of Self-Injection Devices in Diabetes Management Prefilled Syringe Pen Injectors Human Factors Influence the Design of Self Injection Systems Pain Free Shots: A Growing R&D Domain Undiagnosed Diabetes Emerges as a Major Healthcare Challenge, Translates into Untapped Potential for Diabetes Diagnostics Market Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019 Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019 Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices Innovations & Product Advancements: Prime Focus Area for Vendors Focus on Development of Wearable Devices An Insight into Intriguing Advances in Blood Glucose Monitoring Techniques Companies Develop Innovative Needle-Free Alternatives mHealth Solutions for Diabetes Diagnosis Non-invasive Wearable Glucose Testing Devices Innovations in Insulin Pumps 4. GLOBAL MARKET PERSPECTIVE Table 1: World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027 Table 4: World Recent Past, Current & Future Analysis for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Test Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 7: World Recent Past, Current & Future Analysis for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 10: World Recent Past, Current & Future Analysis for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Analog Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 13: World Recent Past, Current & Future Analysis for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Continuous Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 16: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 19: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 22: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 25: World Recent Past, Current & Future Analysis for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 28: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 29: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 31: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 32: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: World 15-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 34: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 35: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 Table 37: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 III. MARKET ANALYSIS UNITED STATES Diabetes Diagnostics Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in the United States for 2022 (E) With Diabetes Emerging as a Major Lifestyle Disease, Diabetes Diagnostics Market Poised for Growth in the US Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045) Diabetes Prevalence by Ethnicity: 2019 Aging Demographics: A Factor Driving Diabetes Prevalence Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030 North American Aging Population (in Thousands) by Age Group: 1975-2050 Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group for 2019 Rising Significance of Wearable and Non-Invasive Glucose Monitoring Devices Regulatory Guidance for Glucose Meter Companies Insulin Syringes Dominate the Insulin Delivery Devices Market Emerging Grey Market for Testing Strips Competition Companies Focus on Research for Better Diabetes Diagnostics Table 40: USA Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: USA Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: USA 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027 Table 43: USA Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: USA Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: USA 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027 CANADA Rising Diabetes Incidence in Canada: Opportunity for Diabetes Diagnostics Market Diabetes Statistics in Canada (2019): Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes (?000s), and Number of Diabetes-Related Deaths (in ?000s) Table 46: Canada Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: Canada Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: Canada 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027 Table 49: Canada Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Canada Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: Canada 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027 JAPAN Diabetes Diagnostics Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in Japan for 2022 (E) Aging Population Drives Diabetes Diagnostics Market Diabetes Statistics in Japan (2019): Number of Adults with Diabetes (in ?000s), Adults with Undiagnosed Diabetes (in ? 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), and Number of Diabetes-Related Deaths (in ?000s) Table 52: Japan Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Japan Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Japan 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027 Table 55: Japan Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Japan Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Japan 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027 CHINA Diabetes Diagnostics Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in China for 2022 (E) Increasing Diabetes Incidence Drives Market Growth Diabetes Statistics in China for 2019 Lower Penetration Offers High Growth Potential Chinese Glucose Meters Breakdown of Revenues by Leading Companies for 2019 Table 58: China Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: China Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: China 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027 Table 61: China Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: China Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: China 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027 EUROPE Diabetes Diagnostics Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in Europe for 2022 (E) Diabetes Diagnostics Market in Europe: A Promising Outlook Diabetes and Population Statistics in Europe (2019, 2030 & 2045) Diabetes Statistics in Europe (2019): Adults with Diabetes (20- 79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years) for Select Countries Reimbursement Scenario Table 64: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 65: Europe Historic Review for Diabetes Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: Europe 15-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 Table 67: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: Europe Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: Europe 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027 Table 70: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: Europe Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: Europe 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027 FRANCE Diabetes Diagnostics Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in France for 2022 (E) Table 73: France Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: France Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: France 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027 Table 76: France Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: France Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: France 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027 GERMANY Diabetes Diagnostics Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in Germany for 2022 (E) Table 79: Germany Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: Germany Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: Germany 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027 Table 82: Germany Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: Germany Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: Germany 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027 ITALY Table 85: Italy Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: Italy Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: Italy 15-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2012, 2021 & 2027 Table 88: Italy Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: Italy Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: Italy 15-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027 UNITED KINGDOM Market Overview Diabetic Foot Ulcers in UK Diabetes Diagnostics Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in the United Kingdom for 2022 (E) Table 91: UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Please contact our Customer Support Center to get the complete Table of Contents Read the full report: https://www.reportlinker.com/p04368322/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________